Biblos-e Archivo. Repositorio Institucional de la UAM
Publicación
Artículo científico (JournalArticle)
Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: A multi-continent study
Background The aim of this study was to evaluate the factors associated with low skeletal muscle mass (SMM), sarcopenia,
and sarcopenic obesity using nationally representative samples of people aged ≥65 years from diverse geographical regions of
the world.
Methods Data were available for 18 363 people aged ≥65 years who participated in the Collaborative Research on Ageing in
Europe survey conducted in Finland, Poland, and Spain, and the World Health Organization Study on global AGEing and adult
health survey conducted in China, Ghana, India, Mexico, Russia, and South Africa, between 2007 and 2012. A skeletal muscle
mass index (SMI) was created to reflect SMM. SMM, SMI, and percent body fat (%BF) were calculated with specific indirect
population formulas. These estimates were based on age, sex, weight, height, and race. Sarcopenia and sarcopenic obesity
were defined with specific cut-offs.
Results The prevalence of sarcopenia ranged from 12.6% (Poland) to 17.5% (India), and that of sarcopenic obesity ranged
from 1.3% (India) to 11.0% (Spain). Higher %BF was associated with lower SMM in all countries, and with sarcopenia in five
countries (p<0.001). Compared to high levels of physical activity, low levels were related with higher odds for sarcopenia
[OR 1.36 (95%CI 1.11–1.67)] and sarcopenic obesity [OR 1.80 (95%CI 1.23–2.64)] in the overall sample. Also, a dosedependent
association between higher numbers of chronic diseases and sarcopenic obesity was observed.
Conclusions Physical activity and body composition changes such as high %BF are key factors for the prevention of
sarcopenia syndrome, SAGE is supported by the United States National Institute on
Aging’s Division of Behavioral and Social Research through
Interagency Agreements (OGHA 04034785; YA1323-08-
CN-0020; Y1-AG-1005-01) and through research grants
(R01-AG034479 and R21-AG034263) and the WHO’s Department
of Health Statistics and Information Systems. The research
leading to these results has received funding from
the European Community’s Seventh Framework Programme
(FP7/2007–2013) under grant agreement number 223071
(COURAGE in Europe), from the Instituto de Salud Carlos IIIFIS
research grants number PS09/00295 and PS09/01845,
and from the Spanish Ministry of Science and Innovation
ACI-Promociona (ACI2009-1010).
Stefanos Tyrovolas received a scholarship from the Foundation
for Education and European Culture (IPEP) to undertake
his post-doctoral research, of which this work is a part.
Ai Koyanagi’s work was supported by the Miguel Servet contract
financed by the CP13/00150 project, integrated into the
National R + D + I and funded by the ISCIII—General Branch
Evaluation and Promotion of Health Research—and the European
Regional Development Fund (ERDF-FEDER). Beatriz
Olaya’s work was supported by the Sara Borrell postdoctoral
programme (reference no. CD12/00429) from the Instituto
de Salud Carlos III (Spain)